Tapimmune Inc is categorized under Commercial Biotechnical Research in Seattle, WA and active since 2011.
Tapimmune Inc was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Glynn Wilson, Chief Executive Officer at the company’s headquarters by writing to 1551 Eastlake Avenue East, Seattle, Washington WA 98102 or by phoning (206) 504-7278. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Tapimmune Inc |
| Contact Person: | Glynn Wilson, Chief Executive Officer |
| Address: | 1551 Eastlake Avenue East, Seattle, Washington 98102 |
| Phone Number: | (206) 504-7278 |
| Website Address: | tapimmune.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2011 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6215110 |
| Share This Business: |
Tapimmune Inc was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Glynn Wilson, Chief Executive Officer for inquiries that concern Tapimmune Inc by calling the company number (206) 504-7278, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Tapimmune Inc can be found at the coordinates 47.63331,-122.32581 as well as the street address 1551 Eastlake Avenue East in Seattle, Washington 98102.
For its online presence, you may visit Tapimmune Inc’s website at tapimmune.com and engage with its social media outlets through on Twitter and on Facebook.